Scott Shreeve takes a critical look at Sermo. Bob Coffield comments from a health-law perspective:
As these new health care business models evolve they raise all sorts of interesting legal questions for health care lawyers. For example, what impact will the recent outing of flea have on the reluctance of physicians to post recommendations/comments on sites like Sermo? Could specific content posts by physicians ultimately be used against them in future litigation to highlight prior inconsistent statements by the physician on a particular course of action or treatment? As Sermo continues to grow what impact will this online collaboration have on the definition of standard of care? How will Sermo respond when it receives a subpeona for records in a pending health care related class action or medical malpractice action?
Related posts:
- More Sermo and Pfizer
- Learning from Sermo
- The AMA and Sermo break up, and how it’s getting ugly
- Sermo responds to privacy concerns
- Medgadget keeps the pressure on Sermo
- The AMA and Sermo
- How private are Sermo conversations?
KevinMD.com on Facebook
Comments on this entry are closed.